drugset / Trial / NCT00818571
Pharmacokinetics of Vildagliptin in Mild, Moderate and Severe Renal Impaired Patients
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study assess the pharmacokinetics of vildagliptin in mild, moderate and severe renal impaired patients
Timeline
- Start
- 2008-12
- Primary completion
- 2009-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vildagliptin | Other / unclassified | 25 mg | — |
| Subject | Vildagliptin | Other / unclassified | 50 mg | — |